Vor Bio Announces Q4 And FY 2022 Results
By Amit Chowdhry ● Mar 24, 2023
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, reported its financial results for the three-month period and full year that ended December 31, 2022, and provided a business update.